Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China

BACKGROUND: Anti-β2GPI-domain I (β2GPI-DI) antibody is pathogenic in patients with antiphospholipid syndrome (APS), but its additional clinical associations and diagnostic value are controversial. METHODS: A total of 378 patients were included, of which 119 patients diagnosed with primary APS, 50 wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yangzhong, Hu, Chaojun, Qi, Wanting, Long, Yin, Huang, Can, Wang, Qian, Tian, Xinping, Zhao, Jiuliang, Li, Mengtao, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445380/
https://www.ncbi.nlm.nih.gov/pubmed/37607781
http://dx.doi.org/10.1136/lupus-2023-000924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445380/
https://www.ncbi.nlm.nih.gov/pubmed/37607781
http://dx.doi.org/10.1136/lupus-2023-000924

Ejemplares similares